Veeva Systems: Q1 Earnings Insights

Comments
Loading...

Shares of Veeva Systems VEEV increased in after-market trading after the company reported Q1 results.

Quarterly Results

Earnings per share were up 37.88% over the past year to $0.91, which beat the estimate of $0.78.

Revenue of $433,573,000 up by 28.62% from the same period last year, which beat the estimate of $410,030,000.

Outlook

Q2 EPS expected between $0.85 and $0.86.

Q2 revenue expected between $450,000,000 and $452,000,000.

Conference Call Details

Date: May 27, 2021

Time: 05:00 PM

ET Webcast URL: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&referrer=https%3A%2F%2Fir.veeva.com%2F&eventid=3081603&sessionid=1&key=BBBF78CD0AE390AF80EE56CF4A0CC7B7&regTag=&V2=false&sourcepage=register

Recent Stock Performance

52-week high: $325.54

52-week low: $183.24

Price action over last quarter: Up 0.49%

Company Overview

Veeva is a leading supplier of software solutions for the life sciences industry. The company's best-of-breed offering addresses operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise and cloud-based platform to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning, or ERP, systems that have limited flexibility. As the vertical leader, Veeva innovates, increases wallet share at existing customers, and expands into other industries with similar regulations, protocols, and procedures, such as consumer goods, chemicals, and cosmetics.

Overview Rating:
Good
62.5%
Technicals Analysis
100
0100
Financials Analysis
40
0100
Overview
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!